2,003 Shares in Intuitive Surgical, Inc. (NASDAQ:ISRG) Acquired by Capital A Wealth Management LLC

Capital A Wealth Management LLC bought a new position in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) in the 4th quarter, according to its most recent filing with the SEC. The institutional investor bought 2,003 shares of the medical equipment provider's stock, valued at approximately $1,045,000. Intuitive Surgical accounts for 1.7% of Capital A Wealth Management LLC's holdings, making the stock its 15th biggest holding.

Other hedge funds have also recently made changes to their positions in the company. Atala Financial Inc purchased a new stake in shares of Intuitive Surgical during the 4th quarter worth $25,000. Parvin Asset Management LLC purchased a new stake in Intuitive Surgical in the fourth quarter valued at about $26,000. BankPlus Trust Department purchased a new stake in Intuitive Surgical in the fourth quarter valued at about $28,000. Hurley Capital LLC acquired a new position in shares of Intuitive Surgical in the fourth quarter valued at about $28,000. Finally, Summit Securities Group LLC acquired a new position in shares of Intuitive Surgical in the fourth quarter valued at about $30,000. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity

In other news, EVP Robert Desantis sold 11,545 shares of the company's stock in a transaction dated Thursday, March 13th. The stock was sold at an average price of $499.22, for a total transaction of $5,763,494.90. Following the completion of the transaction, the executive vice president now directly owns 5,224 shares of the company's stock, valued at approximately $2,607,925.28. This represents a 68.85% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CFO Jamie Samath sold 188 shares of the business's stock in a transaction dated Friday, February 28th. The shares were sold at an average price of $566.94, for a total value of $106,584.72. Following the completion of the sale, the chief financial officer now directly owns 7,162 shares of the company's stock, valued at $4,060,424.28. The trade was a 2.56% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 30,299 shares of company stock valued at $15,470,640. 0.70% of the stock is currently owned by corporate insiders.

Intuitive Surgical Stock Up 0.6%

NASDAQ:ISRG traded up $3.34 on Thursday, reaching $555.75. The company's stock had a trading volume of 1,139,141 shares, compared to its average volume of 1,646,143. Intuitive Surgical, Inc. has a 12-month low of $396.48 and a 12-month high of $616.00. The firm has a market cap of $199.19 billion, a price-to-earnings ratio of 86.70, a price-to-earnings-growth ratio of 5.85 and a beta of 1.70. The stock has a 50 day moving average price of $514.87 and a 200 day moving average price of $538.30.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 EPS for the quarter, beating analysts' consensus estimates of $1.71 by $0.10. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. The company had revenue of $2.25 billion for the quarter, compared to the consensus estimate of $2.19 billion. During the same quarter in the previous year, the business earned $1.50 earnings per share. Equities research analysts expect that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several analysts recently commented on ISRG shares. Barclays dropped their target price on Intuitive Surgical from $684.00 to $635.00 and set an "overweight" rating on the stock in a report on Thursday, April 24th. Erste Group Bank lowered Intuitive Surgical from a "strong-buy" rating to a "hold" rating in a report on Monday, March 17th. Robert W. Baird dropped their target price on Intuitive Surgical from $600.00 to $575.00 and set an "outperform" rating on the stock in a report on Wednesday, April 23rd. BTIG Research set a $560.00 target price on Intuitive Surgical and gave the stock a "buy" rating in a report on Monday, April 14th. Finally, Truist Financial dropped their price objective on Intuitive Surgical from $605.00 to $590.00 and set a "buy" rating on the stock in a report on Wednesday, April 23rd. Five investment analysts have rated the stock with a hold rating and fifteen have given a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average target price of $596.05.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.